C94.01 Acute erythroid leukemia, in remission

Name of the Condition

• Acute erythroid leukemia, in remission
• ICD-10 Code: C94.01

Summary

Acute erythroid leukemia, in remission, is a subtype of acute myeloid leukemia (AML) where the rapid proliferation of immature red blood cell precursors (erythroblasts) in the bone marrow has been controlled by treatment. While the condition is no longer active, ongoing monitoring is necessary to detect potential relapse. This state follows successful therapy, though the underlying malignancy risk persists.

Causes

The exact cause involves genetic mutations or chromosomal abnormalities in hematopoietic stem cells, leading to uncontrolled proliferation of erythroid precursors. Contributing factors may include prior exposure to chemotherapy or radiation, genetic predispositions, or underlying myelodysplastic syndromes.

Risk Factors

• Prior exposure to chemotherapy or radiation
• History of myelodysplastic syndromes
• Certain genetic syndromes (e.g., Down syndrome)
• Advanced age
• Male gender
• Exposure to benzene or other toxic chemicals

Symptoms

• Severe fatigue or weakness
• Unexplained weight loss
• Fever or recurrent infections
• Easy bruising or bleeding
• Shortness of breath
• Pale skin (pallor)
• Enlarged liver or spleen (hepatosplenomegaly)

Diagnosis

Diagnosis involves a physical examination, followed by blood tests (complete blood count, peripheral smear) to confirm remission status. Bone marrow aspiration and biopsy assess residual disease. Molecular testing may detect minimal residual disease (MRD) to guide further management.

Treatment Options

Treatment typically includes chemotherapy to induce remission, followed by consolidation therapy. Stem cell transplantation may be considered for high-risk cases. Ongoing monitoring with blood tests and bone marrow evaluations is standard to detect relapse.

Prognosis and Follow-Up

Prognosis depends on factors like age, genetic mutations, and response to therapy. Regular follow-up with blood counts, bone marrow assessments, and imaging is essential. Relapse risk remains, requiring long-term surveillance.

Complications

• Relapse of leukemia
• Infection due to immunosuppression
• Anemia, thrombocytopenia, or neutropenia
• Organ damage from prior treatment (e.g., chemotherapy-related toxicity)

Lifestyle & Prevention

• Maintain a balanced diet to support overall health
• Avoid exposure to known carcinogens (e.g., benzene)
• Follow recommended vaccination schedules to reduce infection risk
• Engage in regular physical activity as tolerated

When to Seek Professional Help

Seek immediate medical attention for:

• Persistent fever or unexplained weight loss
• Severe fatigue or weakness
• Unusual bruising or bleeding
• Shortness of breath or chest pain
• Signs of infection (e.g., sore throat, cough)

Tips for Medical Coders

Document the remission status clearly in the medical record, as this code specifies the condition is in remission. Ensure coding aligns with clinical documentation of treatment response and ongoing monitoring. Verify that the code is used only when remission is confirmed and documented.